
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
[ Fri, Jul 16th 2021 ]: WOPRAI
David Lebovitz Maintained (ALNY) at Buy with Increased Target to $224 on, Jul 16th, 2021


🞛 This publication is a summary or evaluation of another publication
David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $205 to $224 on, Jul 16th, 2021.
David, nor any peers, have made any analyst calls on ALNY in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30